Target intelligence / Profile preview

Chromosome 6 open reading frame 120 (C6orf120)

Target
C6orf120
Molecular classification
Other (uncharacterized protein family), Putative intrinsically disordered protein (possible based on association with protein-protein interactions and regulatory functions)
01

Overview

C6orf120 (Chromosome 6 open reading frame 120) encodes a protein of largely unknown function that is upregulated in liver hepatocellular carcinoma and serves as a potential diagnostic and prognostic marker. Bioinformatic and experimental studies suggest C6orf120 regulates tumor cell migration, promotes angiogenesis via paracrine signaling mechanisms, and modulates pathways related to metabolism, mRNA processing, and protein modification. Its expression correlates with immune cell infiltration, and it may influence macrophage polarization and immune checkpoint regulation, indicating a role in the tumor microenvironment and possible relevance for immunotherapy strategies. The precise molecular mechanism remains unclear, but the protein is part of gene networks involving other regulatory proteins and noncoding RNAs, notably within the LINC-PINT/miR-1-3p/C6orf120 axis in cancer pathogenesis. No clinically approved drugs target C6orf120 directly as of current knowledge, and its protein family is still largely uncharacterized.

Other names
UPF0669 protein C6orf120bA160E12.4
02

Mechanism of action

mechanisms of targeted drug action are not described; however, potential regulatory axes involve noncoding RNAs and immune checkpoints

03

Biological functions

Regulation of cell migrationModulation of endothelial cell migration and angiogenesisInteraction with metabolic and mRNA surveillance pathwaysImmune modulation (correlation with macrophage polarization; immune checkpoint regulation)Possibly involved in protein modification and mitophagy
04

Disease associations

Cancer (diagnostic and prognostic biomarker, especially in liver hepatocellular carcinoma)Tumor microenvironment regulationPossible immune-related roles in cancer progression
05

Safety considerations

no specific safety concerns reported; challenges pertain to incomplete understanding of biological and therapeutic effects
06

Biomarkers

C6orf120 expression as a diagnostic and prognostic biomarker in liver hepatocellular carcinomaLINC-PINT/hsa-miR-1-3p/C6orf120 regulatory axis as a putative biomarker network

Beyond the preview

Go deeper on Chromosome 6 open reading frame 120 (C6orf120).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 6 open reading frame 120 (C6orf120).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call